Name: Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation (Video) | JoVE Journal
Uploaded: 2016-03-12T14:00:00.000+00:00
Duration: 8 min 30 s
Description: Learn to induce glaucoma-like conditions in rats using episcleral vein saline injection, causing retinal ganglion cell loss. This method enables whole-mount retina preparation for studying neural protection strategies.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

C. Linn is supported by an NIH grant (NIH NEI EY022795).

All procedures using animal subjects have been in accordance with the standards of the Institute of Animal Care and Use Committee (IACUC) at Western Michigan University.
1. Animals
<ol>
	<li>Use male and female rats 3 months of age in this study.</li>
	<li>Keep animals in a 12 hr light/dark cycle with free access to food and water.</li>
</ol>
2. Preparation of KAX Cocktail for Animal Anesthesia
<ol>
	<li>Dissolve 50 mg of xylazine (20 mg/ml) in 5 ml ketamine (100 mg/ml) with 1 ml acepromazine (10 mg/ml) and 3 ml of distilled water. Mix thoroughly.</li>
	<li>Sterilize with a syringe filter and store this solution into a 10 ml serum bottle.</li>
</ol>
3. KAX Injection
<ol>
	<li>Weigh animal (g) and return to cage until ready for injection.</li>
	<li>Inject 0.1 ml&#160;KAX/100 g animal body weight intraperitoneally, using a 1 ml insulin syringe with a 28 G&#160;needle.</li>
	<li>Allow for animal to become unconscious. Check reflexes by pinching the feet and tail.</li>
	<li>Keep all animals safely in lab for the duration of surgery.</li>
	<li>Post-surgery, replace animals into their cages and keep comfortable in RT&#160;until consciousness is regained. Only return animals to the animal facility when the animals awaken and resume normal behavior.</li>
</ol>
4. Preparation for Surgery and Microneedle Assembly
<ol>
	<li>Make a sterile 2 M NaCl solution.</li>
	<li>Use a microelectrode puller (Figure 1C) to pull one 0.86 mm inner diameter heavy polished standard and thin walled borosilicate tube into two finely tapered glass microneedles (Figure 1D, Figure 1E).</li>
	<li>Backfill one microneedle from the previous step with 2 M saline using a backfilling syringe needle and a 1 ml syringe (Figure 1B) . Tap out air bubbles from the tip of the electrode.</li>
	<li>Fill a second 1 ml syringe with 2 M NaCl. Connect an 18 G&#160;needle and then attach a length (approximately 10 inches) of polyethylene tubing (Figure 1A). Use the syringe plunger to fill the polyethylene tubing with saline through the needle.</li>
	<li>When both the microneedle and tubing are filled with saline, carefully connect the two. Eliminate any air in the connection between them (Figure 2).</li>
	<li>Finely bevel the tip of the microneedle by scraping it very lightly against the grain of a course paper towel.</li>
	<li>Check the resistance of the microneedle by gently pushing the plunger on the syringe until a fine stream of liquid can be seen on the paper towel. The stream of liquid should be no wider than 0.5 mm.</li>
</ol>
5. Preparation of Animal
<ol>
	<li>Apply 1 - 2 drops topical anesthetic to cornea (Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%). Wait until no ocular reflex occurs.</li>
	<li>Trim whiskers with scissors.</li>
	<li>Saturate a cotton tip applicator with betadine solution and swab area around the experimental eye.</li>
	<li>Using a microscope, attach a hemostat to clamp the bottom eyelid to bulge the eye, expose the episcleral vein and restrict eye movement. (Figure 3, arrowhead)</li>
</ol>
6. Glaucoma-inducing Saline Injection
<ol>
	<li>When the microneedle assembly and the animal are prepared, begin injections.</li>
	<li>When the animal is confirmed to be unresponsive to feet/tail pinch, carefully pierce the episcleral vein with the microneedle by coming at a low angle between 10 and 20 degrees to the vein (Figure 3, white arrow). A successful puncture into the vein is apparent when blood enters the tip of the microneedle (Figure 3, black arrow).</li>
	<li>Slowly and manually inject approximately 50 &#181;l saline into the vein. This should take approximately 10 sec. The veins will blanch white as the salt circulates through the vasculature (Figure 4, arrowhead). Some regions may maintain a blood red appearance (Figure 4, arrow).
	<ol>
		<li>Perform a second injection into the vein, opposite to the site of the first, to ensure thorough retinal damage to the complete retinal ganglion cell layer. 
		Note: Within minutes, one should see a distinct cloudy appearance through the iris of the eye as the salt circulates through the vascular system.</li>
	</ol>
	</li>
	<li>Leave the opposite eye untreated for use as an internal control.</li>
</ol>
7. Animal Recovery
<ol>
	<li>Remove the hemostat.</li>
	<li>Use a cotton applicator to apply triple antibiotic ointment (Bacitracin zinc, neomycin sulfate, polymysin B sulfate)&#160; to the site clamped by the hemostat and to injection sites. Tissue damage around the eye does not occur using the hemostat.</li>
	<li>&#62;Place anesthetized animals in their cages on a circulating warm water blanket to prevent hypothermia.&#160;Keep animals under observation until consciousness and normal behavior are regained. Transport awake animals back to the animal colony. Animals remain in the colony until the time of sacrifice.</li>
</ol>
8. Animal Sacrifice and Retina Removal
<ol>
	<li>One month following the procedure to induce glaucoma, animals are euthanized by CO2 asphyxiation and secondary thoracic puncture.&#160;
	<ol>
		<li>Place the animal in the chamber and put the lid on securely.</li>
		<li>Open the CO2 and gas regulator valves to allow 20% volume/min CO2 displacement of oxygen in the chamber.</li>
		<li>Allow four to 5 min for the animal to expire.</li>
		<li>Turn off both valves.</li>
		<li>Remove animal from the chamber and perform a secondary thoracic puncture with a sterile scalpel.</li>
	</ol>
	</li>
	<li>After euthanasia, use a scalpel to cut the connective tissue in the orbital cavity surrounding the eye, being careful not to cut into the eyeball itself.</li>
	<li>Carefully use curved edge scissors to cut the optic nerve and any remaining tissue to extract the intact eyeball. Place extracted eyeball in a sterile 60 mm x 15 mm disposable petri dish containing fresh PBS.</li>
	<li>Make an eyecup from the eyeball. To do this, make a small incision with the scalpel just posterior to the border between the iris and the sclera. Follow this incision around the circumference of the eye with small spring scissors to remove the corneal hemisphere from the eyeball. The hemisphere connected to the optic nerve remains.</li>
	<li>Find the very thin pink/beige retina inside the eyecup from the euthanized animal. Hold the pigmented layer of the retina with blunted forceps to stabilize the eyecup. Use another pair of closed forceps to very gently tease the whole intact retina off of the back of the eye. Avoid pinching, pulling, or tugging the retina directly.</li>
	<li>Use small spring scissors to cut the area where the optic nerve is still attached to the retina.</li>
	<li>Be sure to cut away any residual pigment epithelium or scleral tissue from the retina.</li>
	<li>Using a transfer pipette, very gently transfer the isolated retina to a clean sylgard coated 35 mm x 10 mm petri dish containing fresh PBS.</li>
</ol>
9. Whole-Mount Retina Preparation
<ol>
	<li>Once in the sylgard dish, use forceps and one cactus needle to pin the retina in place. Keep the retinal ganglion cell layer facing up and optic nerve down. The retina&#39;s hemispherical shape is notable even after fixation. The curvature of the retina will curl toward the ceiling when the retinal ganglion cell layer is in the desired orientation.</li>
	<li>Use small scissors to cut the retina into four quadrants, making the shape of a four leaf clover radiating from the optic nerve head.</li>
	<li>Pin the quadrants of the retina with additional cactus needles to make the retina as flat as possible without stretching (Figure 5).</li>
	<li>Fix the pinned retinas in the sylgard dish with 3 ml of 4% paraformaldehyde O/N&#160;at RT.</li>
</ol>
10. Antibody Staining of Retina
Note: Stain fixed retinas with primary and secondary antibodies for viewing neurons in the retina (Figure 6).
<ol>
	<li>Rinse fixed, flat-mounted retinas three times for 2 min each in PBS.</li>
	<li>Permeabilize the retinas with 1% Triton X-100 with 1% fetal bovine serum in PBS for 60 min.</li>
	<li>Rinse retinas three times, 2 min each, in PBS.</li>
	<li>Rinse twice with 0.1% Triton X-100 in PBS, 5 min per wash.</li>
	<li>Rinse twice with PBS, 5 min per wash.</li>
	<li>Incubate with 1% Triton X-100 and 1% fetal bovine serum in PBS at RT for 45 min.</li>
	<li>Rinse twice with 0.1% Triton X-100 in PBS, 5 min per wash.</li>
	<li>Rinse twice with PBS, 5 min per wash.</li>
	<li>Incubate each retina in 3 ml 1% fetal bovine serum in PBS with purified mouse anti-rat CD90/mouse CD90.1 (1:300 dilution) O/N at RT.</li>
	<li>Rinse retinas once with 0.1% Triton X-100 in PBS for 5 min.</li>
	<li>Rinse twice with PBS, 5 min per wash.</li>
	<li>Incubate each retina in 3 ml PBS (no FBS) with secondary Alexa Fluor 594 goat anti-mouse IgG (1:300) O/N at RT.</li>
	<li>Wash retinas with PBS liberally.</li>
	<li>Using a dissecting microscope, carefully remove cactus needles from the retina.</li>
	<li>Gently transfer retinas onto microscope slides with a transfer pipette. Be sure to maintain orientation with retinal ganglion cell layer facing to the ceiling. The retina&#39;s hemispherical shape is notable even after fixation. The curvature of the retina will curl toward the ceiling when the retinal ganglion cell layer is in the desired orientation.</li>
	<li>Absorb any excess PBS with KimWipe or other such absorbent material. Be careful not to absorb the retina.</li>
	<li>Add 5 drops of &#189; glycerol and &#189; PBS by weight as a mounting media.</li>
	<li>Cover retina with coverslip, avoiding air bubbles.</li>
	<li>Secure coverslip using clear nail polish, glue, or other adhesive.</li>
</ol>

The authors have no conflicting or competing interests to disclose.

This protocol describes a method of inducing glaucoma-like conditions in an in vivo rat model. This procedure uses an injection of hypertonic saline to induce scarring in the trabecular meshwork 29, 32. Developing scar tissue occludes the outflow of aqueous humor which increases pressure in the anterior chamber. With decreased outflow and pressure build up, the lens suspended by elastic ligaments pushes back into the vitreous chamber. Vitreous humor then applies pressure onto the retina damaging the f...

Glaucoma is a group of eye diseases affecting neurons in the retina, specifically, the retinal ganglion cells1-2. The axons of these cells converge to become the optic nerve carrying visual information to the brain where vision is perceived. Damage to RGCs and their axons therefore causes visual defects.
The primary characteristics associated with glaucoma disorders are RGC degeneration and death, increased intraocular pressure (IOP), and optic disk cupping and atrophy. These features lead to visual field loss or complete, irreversible blindness. Currently, glaucoma has caused blindness in 70 million people worldwide 3. As such, it is the world&#39;s third largest cause of blindness 4.
The exact mechanism of RGC death in glaucoma remains unknown. Much research has been done to unlock the mystery. It is known, however, that the primary risk factor of glaucoma is an increase in intraocular pressure due to irregular circulation of aqueous humor (AH) in the anterior chamber of the eye. AH acts as a transparent and colorless replacement for blood in the avascular anterior chamber of the eye. It nourishes the surrounding cells, removes secreted waste products from metabolic processes, transports neurotransmitters, and permits the circulation of drugs and inflammatory cells within the eye during pathological states 1.
The maintenance of aqueous humor circulation involves the ciliary body and the trabecular meshwork. Aqueous humor is produced by the ciliary body. It then flows into the anterior chamber to maintain the overall health of the ocular tissue. 75 - 80% of aqueous humor outflow is actively secreted through non-pigmentary ciliary epithelium when the fluid is filtered through three layers of spongy tissue in the ciliary muscle. The fluid exits through the trabecular meshwork and through Schlemm&#39;s Canal which empties into the blood system 5.The remaining 20 - 25% of outflow bypasses the trabecular meshwork and is passively secreted by ultrafiltration and diffusion through the uveo-scleral pathway. This pathway appears to be relatively independent of intraocular pressure 1.
When aqueous humor production and outflow are out of balance, pressure builds within the eye. As stated, this increase in intraocular pressure is the primary risk factor in the development of glaucoma. Such pressure causes damage to the intricate layers of neurons in the retina at the back of the eye. Damage to the retinal ganglion cell axons of the optic nerve causes the brain to no longer receive accurate visual information. As a result, the perception of vision is lost and complete blindness can occur.
To date, there is no cure for glaucoma. Different treatment methods exist that primarily aim to reduce intraocular pressure. These include topical medication classes such as beta1-adrenergic receptor blockers, or topical prostaglandin analogues. Beta blockers reduce the intraocular pressure by decreasing the production of aqueous humor 7. Prostaglandins function to reduce IOP by increasing the outflow of aqueous humor 8-14. Alpha adrenergic agonists and carbonic anhydrase inhibitors are also used as secondary methods of treatment. Alpha adrenergic agonists increase outflow through the uveoscleral pathway 15-17. Carbonic anhydrase inhibitors reduce the production of AH by enzymatic inhibition 18. Much more invasive procedures are also being used to treat glaucoma. Laser trabeculoplasty is used to increase the outflow of aqueous humor 19. Another surgical therapy, called trabeculectomy, creates an alternative drainage site to filter AH when the traditional trabecular pathway is blocked 20-21.
These treatment options have been known to effectively reduce IOP. However, up to 40% of glaucoma patients show normal IOP levels indicating a need for more complete therapeutic methods.22,23 Additionally, retinal ganglion cell death seen in glaucoma is irreversible once it begins and current treatments do not stop the progression of the disease 24-28. This has highlighted the need for effective neuroprotective therapies that target the survival of the neurons themselves. Development of glaucoma models is crucial for this development.
In this study we are demonstrating a method of inducing glaucoma-like effects in adult Long Evans rats using a modified procedure originally outlined by Morrison29. In this procedure, injections of 2 M hypertonic saline into the episcleral venous plexus induces glaucoma-like conditions by scarring tissue to reduce aqueous humor outflow in the trabecular meshwork leading to an increase in intraocular pressure and a significant loss of RGCs within one month of the procedure 30-31. Glaucoma-inducing procedures, such as the one described here, may be the key to unlocking new developments in glaucoma treatments.

<table><tbody><tr><td>Xylazine hydrochloride, Minimum 99%</td><td>Sigma, Life Science</td><td>X1251-1G</td><td></td></tr><tr><td>Ketamine hydrochloride injection, USP, 100mg/ml&amp;nbsp;</td><td>Putney, Inc</td><td>NDC 26637-411-01</td><td>10 ml bottle</td></tr><tr><td>Acepromazine Maleate, 10mg/ml</td><td>Phoenix Pharmaceutical, Inc</td><td>NDC 57319-447-04, 670008L-03-0408</td><td>50 ml bottle</td></tr><tr><td>Serum bottle, 10 ml</td><td>VWR</td><td>16171319</td><td>Borosilicate glass</td></tr><tr><td>1 ml insulin syringe&amp;nbsp;</td><td>VWR</td><td>BD329410</td><td>28 G needle&amp;nbsp;</td></tr><tr><td>Sodium chloride</td><td>Sigma&amp;nbsp;</td><td>S7653</td><td>2 M Solution&amp;nbsp;</td></tr><tr><td>Microelectrode Puller&amp;nbsp;</td><td>Narishige Group</td><td>PP-830</td><td></td></tr><tr><td>Heavy Polished Standard and Thin Walled Borosilicate Tubing&amp;nbsp;</td><td>Sutter Instruments</td><td>B150-86-10HP</td><td>without filament, 0.86 mm</td></tr><tr><td>Microfil syringe needle for filling micropipettes</td><td>World Precision Instruments, Inc</td><td>MF28G</td><td></td></tr><tr><td>18 gauge Luer-Lock needle</td><td>Fisher Scientific</td><td>1130421</td><td>Syringe needle</td></tr><tr><td>Flexible Polyethylene Tubing</td><td>Fisher Scientific</td><td>22046941</td><td>0.034 inch diameter, approximately 10 inches&amp;nbsp;</td></tr><tr><td>Proparacaine Hydrochloride Opthalmic Solution, USP, 0.5%</td><td>Akorn, Inc</td><td>NDC 17478-263-12</td><td>15 ml&amp;nbsp; sterile bottle&amp;nbsp;</td></tr><tr><td>Curved Scissors</td><td>Fine Science Tools</td><td>14061-11</td><td></td></tr><tr><td>Microscope</td><td>Leica&amp;nbsp;</td><td>StereoZoom 4</td><td></td></tr><tr><td>Hemostat Clamp&amp;nbsp;</td><td>Fine Science Tools</td><td>1310912</td><td>curved edge</td></tr><tr><td>Triple Antibiotic Ointment&amp;nbsp;</td><td>Fisher Scientific</td><td>NC0664481</td><td></td></tr><tr><td>Scalpel handle</td><td>Fine Science Tools&amp;nbsp;</td><td>10004-13</td><td></td></tr><tr><td>Scalpel blade #11</td><td>Fine Science Tools&amp;nbsp;</td><td>10011-00</td><td></td></tr><tr><td>60 mm x 15 mm Disposable Petri Dish</td><td>VWR</td><td>351007</td><td></td></tr><tr><td>Phosphate Buffered Saline 10x Concentrate</td><td>Sigma, Life Science&amp;nbsp;</td><td>P7059-1L</td><td>1x dilution&amp;nbsp;</td></tr><tr><td>Spring Scissors</td><td>Fine Science Tools&amp;nbsp;</td><td>15009-08</td><td></td></tr><tr><td>Forceps (2), Dumont # 5</td><td>Fine Science Tools</td><td>11251-30</td><td></td></tr><tr><td>3 ml Transfer Pipets, polyethylene, non sterile</td><td>BD Biosciences</td><td>357524 or 52947-948</td><td>1 and 2 ml graduations</td></tr><tr><td>35 mm x 10 mm Easy Grip Petri Dish&amp;nbsp;</td><td>BD Biosciences</td><td>351008</td><td></td></tr><tr><td>Sylgard 184</td><td>VWR</td><td>102092-312</td><td></td></tr><tr><td>Cactus Needles</td><td></td><td></td><td></td></tr><tr><td>Paraformaldehyde</td><td>EMD Millipore&amp;nbsp;</td><td>PX0055-3 or 818715.0100</td><td>Made into a 4% solution&amp;nbsp;</td></tr><tr><td>Triton X-100</td><td>Sigma&amp;nbsp;</td><td>T9284-100 ml</td><td>Made into both a 1% and 0.1% solution&amp;nbsp;</td></tr><tr><td>Fetal Bovine Serum&amp;nbsp;</td><td>Atlanta Biological</td><td>S11150</td><td>500 ml</td></tr><tr><td>Purified Mouse Anti-Rat CD90/mouse CD90.1</td><td>BD Pharmingen</td><td>Cat 554892</td><td>1:300 dilution&amp;nbsp;</td></tr><tr><td>Alexa Fluor 594 goat anti-mouse&amp;nbsp;</td><td>Life Technologies&amp;nbsp;</td><td>A11005</td><td>1:300 dilution&amp;nbsp;</td></tr><tr><td>Microscope Slides</td><td>Corning&amp;nbsp;</td><td>2948-75x25</td><td></td></tr><tr><td>Glycerol&amp;nbsp;</td><td>Sigma&amp;nbsp;</td><td>G5516-100 ml&amp;nbsp;</td><td>50% glycerol to 50% PBS, by weight&amp;nbsp;</td></tr><tr><td>Coverglass&amp;nbsp;</td><td>Corning&amp;nbsp;</td><td>2975-225</td><td>Thickness 1 22 x 50 mm&amp;nbsp;</td></tr><tr><td>Confocal Microscope</td><td>Nikon&amp;nbsp;</td><td>C2 Eclipse Ti</td><td></td></tr></tbody></table>

glaucoma-inducing procedure in an in vivo rat model and whole-mount retina preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma is a disease of the central nervous system affecting retinal ganglion cells (RGCs). RGC axons making up the optic nerve carry visual input to the brain for visual perception. Damage to RGCs and their axons leads to vision loss and/or blindness. Although the specific cause of glaucoma is unknown, the primary risk factor for the disease is an elevated intraocular pressure. Glaucoma-inducing procedures in animal models are a valuable tool to researchers studying the mechanism of RGC death. Such information can lead to the development of effective neuroprotective treatments that could aid in the prevention of vision loss. The protocol in this paper describes a method of inducing glaucoma - like conditions in an in vivo rat model where 50 &#181;l of 2 M hypertonic saline is injected into the episcleral venous plexus. Blanching of the vessels indicates successful injection. This procedure causes loss of RGCs to simulate glaucoma. One month following injection, animals are sacrificed and eyes are removed. Next, the cornea, lens, and vitreous are removed to make an eyecup. The retina is then peeled from the back of the eye and pinned onto sylgard dishes using cactus needles. At this point, neurons in the retina can be stained for analysis. Results from this lab show that approximately 25% of RGCs are lost within one month of the procedure when compared to internal controls. This procedure allows for quantitative analysis of retinal ganglion cell death in an in vivo rat glaucoma model.

This section illustrates the apparatus components and procedure used to induce glaucoma-like conditions in an in vivo rat glaucoma model. We show the individual tools and equipment used to perform a hypertonic saline injection which causes an increase in intraocular pressure. We show the injection into the episcleral venous plexus with its characteristic blanching effect and the cloudy appearance of the anterior chamber that results. We also describe the process of retina removal...

Glaucoma is characterized by damage to retinal ganglion cells. Inducing glaucoma in animal models can provide insight into the study of this disease. Here, we outline a procedure that induces loss of RGCs in an in vivo rat model and demonstrates the preparation of whole-mount retinas for analysis.

Glaucoma is a disease of the central nervous system affecting retinal ganglion cells (RGCs). RGC axons making up the optic nerve carry visual input to the ...

The overall goal of this procedure is to create significant loss of retinal ganglion cells in the rat retina by inducing glaucoma-like conditions. This method can help answer key questions in the fields of glaucoma and neural protection. The main advantage of this technique is that it causes a gradual loss of retinal ganglion cells, similar to that seen in human glaucoma.To begin this procedure, pull two finely-tapered glass microneedles from a heavy polished standard thin-walled Borosilicate Tube with a microelectrode puller. Then, backfill one microneedle with two molar saline, using a one milliliter syringe. Tap out the air bubbles from the tip of the electrode.Next, fill a second one milliliter syringe with two molar NaCl. Connect it to an 18 gauge needle, and then attach the needle to 10-inch polyethylene tubing. Use the syringe plunger to fill the polyethylene tubing with saline through the needle.When both the microneedle and tubing are filled with saline, carefully connect the two. Eliminate any air in the connection by tapping out the air bubbles. Then, scrape the microneedle tip lightly against a paper towel to finely bevel it.Check the resistance of the microneedle by ge

glaucoma-inducing-procedure-an-vivo-rat-model-whole-mount-retina

Research

JoVE Journal

Medicine

Source: Bosco, A., et al. In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma. J. Vis. Exp. (2015) This video demonstrates in vivo imaging of retinal microglia in a mouse model of glaucoma. A transgenic mouse with fluorescent protein-expressing retinal microglia is positioned under an ophthalmoscope. Infrared illumination is used to locate the optic nerve head (ONH), and the focal plane is...

In Vivo Imaging of Retinal Microglia in a Mouse Model of Glaucoma

The protocol described here is for structural assessment of a wholemount retinal preparation. This includes descriptions of tissue dissection, mounting onto a hydrophilized polytetrafluoroethylene (PTFE) membrane insert, bolus loading with fluorescent markers, and a comparison of fixation with carbodiimide and paraformaldehyde for immunohistochemical analysis of cellular and synaptic components.

Optimized Protocol for Retinal Wholemount Preparation for Imaging and Immunohistochemistry

Immunohistochemistry protocols are used to study the localization of a specific protein in the retina. Calcium imaging techniques are employed to study calcium dynamics in retinal ganglion cells and their axons.

Immunohistochemical and Calcium Imaging Methods in Wholemount Rat Retina

Here, we present a protocol to induce ocular hypertension in the murine eye that results in the loss of retinal ganglion cells as observed in glaucoma. Magnetic microbeads are injected into the anterior chamber and attracted to the iridocorneal angle using a magnet to block the outflow of aqueous humour.

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

The following report describes how to replicate the rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION), using the appropriate dye, contact lens and laser parameters. We also reveal the appropriate steps for evaluating the rNAION lesion in vivo.

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rNAION)

This protocol describes a novel method for investigating a form of chemical neurostimulation of wholemount rat retinas in vitro with the neurotransmitter glutamate. Chemical neurostimulation is a promising alternative to the conventional electrical neurostimulation of retinal neurons for treating irreversible blindness caused by photoreceptor degenerative diseases.

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

We demonstrate three different tissue preparation techniques for immunohistochemical visualization of rat retinal microvascular pericytes, i.e., cryo-sections, whole-mounts, and hypotonic isolation of the vascular network.

Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes

Chronic ocular hypertension is induced by applying a circumlimbal suture in rats and mice, leading to functional and structural deterioration of the retinal ganglion cells consistent with glaucoma.

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Diabetic retinopathy is one of the leading causes of blindness. Histology, blood-retinal barrier breakdown assay, and fluorescence angiography are valuable techniques to understand the pathophysiology of the retina, which could further enhance the efficient drug screening against diabetic retinopathy.

Retinal Pathophysiological Evaluation in a Rat Model

The goal of this protocol is to characterize a novel model of glaucomatous neurodegeneration based on 360° thermic cauterization of limbal vascular plexus, inducing subacute ocular hypertension.

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

This protocol describes the procedure for isolating the whole-mount mouse retina and performing immunostaining to label all retinal ganglion cells (RGCs). The process is followed by imaging and automatically counting RGCs using AI-based software, providing a simple, fast, and accurate method for quantifying RGCs in the entire mouse retina.

Whole-Mount Immunostaining and Automatic Counting of Mouse Retinal Ganglion Cells

Learn to induce glaucoma-like conditions in rats using episcleral vein saline injection, causing retinal ganglion cell loss. This method enables whole-mount retina preparation for studying neural protection strategies.

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Explore More Videos